Scientists seeking new ways to fight drug-resistant superbugs have mapped the genomes of more than 3,000 bacteria, including samples of a bug taken from Alexander Fleming’s nose and a dysentery-causing strain from a World War One soldier.
Shortages of some life-saving antibiotics are putting growing numbers of patients at risk and fueling the evolution of “superbugs” that do not respond to modern medicines, according to a new report.
The number of people struck down by a virus causing vomiting and diarrhea at the Pyeongchang Winter Olympics has more than doubled to 86, though athletes remain unaffected, the Korean Centers for Disease Control and Prevention (KCDC) said.
Drugmakers’ response to the threat posed by “superbugs” remains patchy even after years of warnings, according to the first analysis of individual companies’ efforts to tackle the antibiotic resistance crisis.
The Bill and Melinda Gates Foundation invested up to $40 million in Oxford, UK-based Immunocore. Immunocore is a T-cell Receptor (TCR) company that has largely focused on immuno-oncology, but is making the transition to infectious diseases.
At least three people worldwide are infected with totally untreatable “superbug” strains of gonorrhoea which they are likely to be spreading to others through sex, the World Health Organization (WHO) said.
One of the most hated short-term illnesses – which has been carving a swath of destruction through U.S. households in 2017 – is the norovirus, a gastrointestinal bug that has shut down schools and families across the United States.
Eleven biotech companies and research teams in Britain and the United States were awarded up to $48 million in funding to speed development of new antibiotics powerful enough to take on the world’s deadliest superbugs.
Merck is globally committed to an antimicrobial stewardship encompassing surveillance, R&D, and health policy.
The World Health Organization has suspended the approval of tuberculosis drugs made by India’s Svizera Labs, a major supplier to developing countries, following an investigation into standards.